|
|
Problem: Providing a composition with an action of decreasing uric acid
level in human sera from a residue from distillation of distilled spirits
from barley as a material having been disposed so far despite no safety
problem, by a simple treatment method suitable for practical
industrial-scale production without any complex purification step.
Means for Solving the Problem: A serum uric acid level-decreasing agent
containing as the active ingredient a component from barley subjected to
fermentation, preferably a residue from distillation of distilled spirits
from barley, or a liquid fraction (residual solution from distillation of
distilled spirits from barley) obtained by subjecting the residue from
distillation of distilled spirits from barley to a separation procedure
to a solid fraction and the liquid fraction, and/or a composition
obtained by fractionating the residual solution from distillation of
distilled spirits from barley, which is preferably a pharmaceutical agent
for the prophylaxis or therapeutic treatment of diseases requiring the
decrease of serum uric acid level. A composition containing the serum
uric acid level-decreasing agent is in a form of foods and drinks,
pharmaceutical products and quasi-pharmaceutical products, or feeds.
Foods and drinks with a label telling that the foods and the drinks are
used for the prophylaxis of diseases requiring the decrease of serum uric
acid level, preferably functional foods and drinks, foods and drinks as
nutritious supplements or healthy foods and drinks, for decreasing serum
uric acid level.
|
|
|
< Method of enhancing blood antioxidant activity ingesting a compound in the form of at least one form selected from amongst juice, powder, granule, tablet and capsule, which contains an effective amount of at least one vegetable selected from the group consisting of broccoli, spinach, parsley, komatsuna (Brassicad rapa L.) and japanese radish leaves, and at least one vegetable selected from amongst lettuce, cabbage and celery
< Determining nutrients for animals through gene expression
> THIAZOLHYDRAZIDES FOR TREATMENT OF NEURODEGENERATIVE DISEASES
> GRAFT PROSTHESIS, MATERIALS AND METHODS
|
~ 00613
|